JP2023504185A5 - - Google Patents
Info
- Publication number
- JP2023504185A5 JP2023504185A5 JP2022532869A JP2022532869A JP2023504185A5 JP 2023504185 A5 JP2023504185 A5 JP 2023504185A5 JP 2022532869 A JP2022532869 A JP 2022532869A JP 2022532869 A JP2022532869 A JP 2022532869A JP 2023504185 A5 JP2023504185 A5 JP 2023504185A5
- Authority
- JP
- Japan
- Prior art keywords
- epitope
- cells
- antigen
- soluble polyvalent
- binding sites
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962943166P | 2019-12-03 | 2019-12-03 | |
| US62/943,166 | 2019-12-03 | ||
| PCT/US2020/063177 WO2021113558A2 (en) | 2019-12-03 | 2020-12-03 | METHODS FOR EXPANDING γδ T-CELL POPULATIONS WITH MULTIVALENT AGENTS AND COMPOSITIONS THEREOF |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023504185A JP2023504185A (ja) | 2023-02-01 |
| JP2023504185A5 true JP2023504185A5 (enExample) | 2024-01-31 |
Family
ID=76222296
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022532869A Pending JP2023504185A (ja) | 2019-12-03 | 2020-12-03 | γδＴ細胞集団を多価薬剤で増殖させるための方法及びその組成物 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230009275A1 (enExample) |
| EP (1) | EP4072567A4 (enExample) |
| JP (1) | JP2023504185A (enExample) |
| KR (1) | KR20220123652A (enExample) |
| CN (1) | CN115397976A (enExample) |
| AU (1) | AU2020398623A1 (enExample) |
| CA (1) | CA3160609A1 (enExample) |
| IL (1) | IL293459A (enExample) |
| MX (1) | MX2022006547A (enExample) |
| WO (1) | WO2021113558A2 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20250066477A1 (en) * | 2022-01-05 | 2025-02-27 | Inhibrx Biosciences, Inc. | Gamma Delta T-Cell-Binding Polypeptides and Uses Thereof |
| EP4508193A4 (en) * | 2022-04-11 | 2026-04-29 | In8Bio Inc | IPSC-BASED GAMMA-DELTA T LYMPHOCYTES: COMPOSITIONS AND METHODS OF USE |
| WO2025082502A1 (en) * | 2023-10-18 | 2025-04-24 | Nanjing Legend Biotech Co., Ltd. | Pan t cells and methods of manufacturing of the same |
| WO2026013158A1 (en) * | 2024-07-10 | 2026-01-15 | Cytospire Therapeutics Limited | Antibodies binding to constant domains of gamma delta t-cell receptors |
| WO2026013159A1 (en) * | 2024-07-10 | 2026-01-15 | Cytospire Therapeutics Limited | Antibodies binding to constant domains of gamma delta t-cell receptors |
| WO2026087747A1 (en) | 2024-10-24 | 2026-04-30 | Avidicure Ip B.V. | Multispecific antigen binding proteins for tumor-targeting of γδ1 t cells and use thereof |
| WO2026087748A1 (en) | 2024-10-24 | 2026-04-30 | Avidicure Ip B.V. | Multispecific antigen binding proteins for the expansion of γδ t cells and use thereof |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU7729000A (en) * | 1999-09-30 | 2001-04-30 | National Jewish Medical And Research Center | Modulation of gammadelta t cells to regulate airway hyperresponsiveness |
| ES2808914T3 (es) * | 2014-09-04 | 2021-03-02 | Stemcell Tech Inc | Complejos de anticuerpo solubles para la activación y expansión de linfocitos T o células NK |
| IL252131B2 (en) * | 2014-11-17 | 2023-04-01 | Adicet Bio Inc | Transgenic gamma delta T cells |
| MX2018013864A (es) * | 2016-05-12 | 2019-06-10 | Adicet Bio Inc | Métodos para la expansión selectiva de poblaciones de células t gama y composicicones de estas. |
| GB201707048D0 (en) * | 2017-05-03 | 2017-06-14 | King S College London | Expansion of gamma delta cells, compositions, and methods of use thereof |
| MX2020005005A (es) * | 2017-11-15 | 2020-08-27 | Adicet Bio Inc | Métodos para la expansión selectiva de poblaciones de células t gamma delta delta 3 y composiciones de estas. |
| DE102017127984B4 (de) * | 2017-11-27 | 2019-12-05 | Immatics US, Inc. | Verfahren für die Vermehrung und Aktivierung von γδ-T-Zellen |
| CA3126896A1 (en) * | 2018-12-03 | 2020-06-11 | Adicet Bio Inc. | Methods for selective in vivo expansion of .gamma. .delta. t-cell populations and compositions thereof |
-
2020
- 2020-12-03 KR KR1020227022477A patent/KR20220123652A/ko active Pending
- 2020-12-03 EP EP20896270.4A patent/EP4072567A4/en active Pending
- 2020-12-03 MX MX2022006547A patent/MX2022006547A/es unknown
- 2020-12-03 AU AU2020398623A patent/AU2020398623A1/en active Pending
- 2020-12-03 US US17/782,129 patent/US20230009275A1/en active Pending
- 2020-12-03 IL IL293459A patent/IL293459A/en unknown
- 2020-12-03 CN CN202080094563.5A patent/CN115397976A/zh active Pending
- 2020-12-03 JP JP2022532869A patent/JP2023504185A/ja active Pending
- 2020-12-03 CA CA3160609A patent/CA3160609A1/en active Pending
- 2020-12-03 WO PCT/US2020/063177 patent/WO2021113558A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021000117A5 (enExample) | ||
| RU2018118575A (ru) | Способы культивирования клеток и наборы и устройство для них | |
| Sarkar et al. | The role of T helper type 17 cells in inflammatory arthritis | |
| RU2016143385A (ru) | Продукты определенного состава, содержащие генетически модифицированные т-клетки | |
| JP2016509839A5 (enExample) | ||
| JP2020530440A5 (enExample) | ||
| Boyman et al. | IL-7/anti-IL-7 mAb complexes restore T cell development and induce homeostatic T Cell expansion without lymphopenia | |
| JP2024041873A5 (enExample) | ||
| JP5894538B2 (ja) | 炎症性ヒトＴｈ１７細胞の増殖および機能を決定的に調節するＩＣＯＳ | |
| JP2024506557A5 (enExample) | ||
| JP2006519228A5 (ja) | 抗原に対し霊長類を免疫寛容化する抗体の使用法 | |
| CA2796379A1 (en) | Method for proliferation of antigen-specific t cells | |
| JP2021534785A5 (enExample) | ||
| Oppenheim et al. | The role of cytokines in cancer | |
| JP2006507231A5 (enExample) | ||
| CA2148712A1 (en) | Peripheralization of hematopoietic stem cells | |
| JP2022541523A5 (enExample) | ||
| JP2024521185A5 (enExample) | ||
| JP2022553822A5 (enExample) | ||
| Hoornaert et al. | In vivo interleukin-13-primed macrophages contribute to reduced alloantigen-specific T cell activation and prolong immunological survival of allogeneic mesenchymal stem cell implants | |
| US20240115603A1 (en) | Modified Extracellular Domain of Granulocyte Colony-Stimulating Factor Receptor (G-CSFG) and Cytokines Binding Same | |
| JP2020527044A5 (enExample) | ||
| Yang et al. | Immunophenotype and antitumor activity of cytokine-induced killer cells from patients with hepatocellular carcinoma | |
| Reading et al. | Augmented expansion of Treg cells from healthy and autoimmune subjects via adult progenitor cell co-culture | |
| Sang et al. | Regional, but not systemic recruitment/expansion of dendritic cells by a pluronic-formulated Flt3-ligand plasmid with vaccine adjuvant activity |